Nifty
Sensex
:
:
24381.70
80025.50
-31.80 (-0.13%)
-123.38 (-0.15%)

Pharmaceuticals & Drugs

Rating :
52/99

BSE: 524824 | NSE: BALPHARMA

122.95
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  119.05
  •  124.90
  •  119.05
  •  119.91
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  97997
  •  120.50
  •  132.45
  •  81.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 184.88
  • 25.01
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 311.23
  • 1.03%
  • 2.67

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.23%
  • 0.48%
  • 32.35%
  • FII
  • DII
  • Others
  • 0.13%
  • 0.00%
  • 15.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.45
  • 6.22
  • 6.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.52
  • 7.39
  • 0.48

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.57
  • -7.48
  • -18.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 36.17
  • 27.37
  • 38.64

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.00
  • 2.05
  • 2.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.82
  • 11.56
  • 9.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
94.63
82.45
14.77%
81.66
76.62
6.58%
92.54
75.31
22.88%
70.39
69.84
0.79%
Expenses
85.03
74.29
14.46%
73.87
70.47
4.82%
84.84
69.53
22.02%
63.94
64.81
-1.34%
EBITDA
9.59
8.16
17.52%
7.80
6.15
26.83%
7.70
5.77
33.45%
6.44
5.03
28.03%
EBIDTM
10.14%
9.90%
9.55%
8.03%
8.32%
7.67%
9.16%
7.21%
Other Income
2.45
0.19
1,189.47%
0.10
0.46
-78.26%
0.14
0.05
180.00%
0.16
0.24
-33.33%
Interest
4.14
3.85
7.53%
3.66
3.11
17.68%
3.82
2.86
33.57%
3.64
2.37
53.59%
Depreciation
2.16
2.09
3.35%
2.96
2.45
20.82%
2.42
2.37
2.11%
2.53
2.23
13.45%
PBT
5.75
2.41
138.59%
1.27
1.05
20.95%
1.60
0.60
166.67%
0.43
0.68
-36.76%
Tax
0.22
0.79
-72.15%
0.42
0.46
-8.70%
0.63
0.47
34.04%
0.34
0.40
-15.00%
PAT
5.53
1.62
241.36%
0.85
0.59
44.07%
0.97
0.13
646.15%
0.10
0.28
-64.29%
PATM
5.85%
1.96%
1.04%
0.77%
1.05%
0.17%
0.14%
0.41%
EPS
3.46
1.02
239.22%
0.56
0.37
51.35%
0.60
0.07
757.14%
0.05
0.19
-73.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
339.22
304.22
281.21
250.53
171.09
225.01
209.29
228.91
198.32
187.16
178.87
Net Sales Growth
11.50%
8.18%
12.25%
46.43%
-23.96%
7.51%
-8.57%
15.42%
5.96%
4.63%
 
Cost Of Goods Sold
191.75
158.95
155.74
140.87
75.74
104.04
88.57
103.94
94.06
87.49
83.74
Gross Profit
147.47
145.27
125.48
109.66
95.35
120.96
120.71
124.97
104.25
99.67
95.14
GP Margin
43.47%
47.75%
44.62%
43.77%
55.73%
53.76%
57.68%
54.59%
52.57%
53.25%
53.19%
Total Expenditure
307.68
278.97
257.24
225.88
166.07
207.33
191.95
214.10
183.46
170.05
161.00
Power & Fuel Cost
-
7.73
5.89
4.98
4.76
6.38
6.07
6.17
4.66
4.54
4.39
% Of Sales
-
2.54%
2.09%
1.99%
2.78%
2.84%
2.90%
2.70%
2.35%
2.43%
2.45%
Employee Cost
-
55.30
47.25
41.88
50.44
50.28
52.16
45.37
37.30
32.24
28.12
% Of Sales
-
18.18%
16.80%
16.72%
29.48%
22.35%
24.92%
19.82%
18.81%
17.23%
15.72%
Manufacturing Exp.
-
27.76
21.92
18.62
15.80
20.28
18.03
21.44
19.80
20.78
18.23
% Of Sales
-
9.12%
7.79%
7.43%
9.23%
9.01%
8.61%
9.37%
9.98%
11.10%
10.19%
General & Admin Exp.
-
10.16
8.07
5.47
7.48
9.27
11.21
16.82
13.98
12.43
11.54
% Of Sales
-
3.34%
2.87%
2.18%
4.37%
4.12%
5.36%
7.35%
7.05%
6.64%
6.45%
Selling & Distn. Exp.
-
16.36
14.86
10.28
10.61
15.74
15.63
19.50
13.18
11.91
13.49
% Of Sales
-
5.38%
5.28%
4.10%
6.20%
7.00%
7.47%
8.52%
6.65%
6.36%
7.54%
Miscellaneous Exp.
-
2.72
3.51
3.79
1.23
1.33
0.27
0.86
0.47
0.65
13.49
% Of Sales
-
0.89%
1.25%
1.51%
0.72%
0.59%
0.13%
0.38%
0.24%
0.35%
0.83%
EBITDA
31.53
25.25
23.97
24.65
5.02
17.68
17.34
14.81
14.86
17.11
17.87
EBITDA Margin
9.29%
8.30%
8.52%
9.84%
2.93%
7.86%
8.29%
6.47%
7.49%
9.14%
9.99%
Other Income
2.85
0.94
5.15
1.14
1.85
1.01
1.73
3.04
1.28
1.17
0.65
Interest
15.26
12.31
10.91
12.16
12.73
12.74
9.41
8.49
6.48
6.52
7.16
Depreciation
10.07
9.13
9.04
9.52
7.68
6.16
6.77
6.49
7.01
7.02
4.74
PBT
9.05
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
Tax
1.61
2.13
3.48
-0.61
-0.64
-2.36
2.51
3.27
2.39
1.19
1.55
Tax Rate
17.79%
44.84%
37.91%
-14.88%
4.73%
1180.00%
87.15%
113.94%
90.19%
25.11%
23.38%
PAT
7.45
2.57
5.61
4.74
-12.22
3.79
2.79
1.75
1.41
3.62
5.07
PAT before Minority Interest
7.40
2.62
5.70
4.71
-12.89
2.15
0.38
-0.40
0.26
3.55
5.07
Minority Interest
-0.05
-0.05
-0.09
0.03
0.67
1.64
2.41
2.15
1.15
0.07
0.00
PAT Margin
2.20%
0.84%
1.99%
1.89%
-7.14%
1.68%
1.33%
0.76%
0.71%
1.93%
2.83%
PAT Growth
184.35%
-54.19%
18.35%
-
-
35.84%
59.43%
24.11%
-61.05%
-28.60%
 
EPS
4.72
1.63
3.55
3.00
-7.73
2.40
1.77
1.11
0.89
2.29
3.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
63.79
58.63
53.58
52.43
66.64
64.99
62.45
54.90
55.20
50.05
Share Capital
15.69
14.82
14.82
14.17
14.17
14.17
14.17
12.87
12.87
11.11
Total Reserves
48.10
42.87
37.82
38.25
52.47
50.82
48.27
40.01
40.31
37.20
Non-Current Liabilities
37.97
36.40
34.19
33.56
37.85
45.57
30.02
45.12
16.34
17.92
Secured Loans
30.52
27.01
23.93
22.93
28.76
33.25
12.76
15.24
6.11
6.58
Unsecured Loans
0.00
0.00
0.00
0.22
0.00
1.43
5.04
19.71
0.53
1.39
Long Term Provisions
5.07
4.69
4.07
3.62
2.71
2.05
3.42
2.28
1.65
1.06
Current Liabilities
209.33
165.65
152.53
159.49
163.24
154.40
143.24
111.19
92.36
86.77
Trade Payables
78.92
65.56
47.17
38.67
47.34
49.96
54.43
46.85
38.53
33.53
Other Current Liabilities
31.05
24.21
23.57
30.69
27.86
33.77
16.45
12.01
11.86
8.66
Short Term Borrowings
92.72
70.75
80.82
89.63
87.08
68.31
71.07
50.09
40.14
42.75
Short Term Provisions
6.64
5.12
0.98
0.50
0.96
2.37
1.29
2.24
1.83
1.83
Total Liabilities
311.00
260.55
240.07
238.38
261.31
260.17
233.33
211.03
163.87
154.74
Net Block
76.46
67.39
68.59
70.71
70.39
71.48
59.98
56.23
52.20
55.18
Gross Block
127.10
111.45
105.10
97.70
89.76
84.71
66.44
106.10
95.14
90.11
Accumulated Depreciation
50.64
44.06
36.52
27.00
19.37
13.23
6.46
49.87
42.95
34.93
Non Current Assets
82.85
75.96
75.93
81.02
78.26
75.41
68.78
68.03
58.74
59.63
Capital Work in Progress
0.00
1.61
0.00
3.32
3.63
0.21
1.70
3.93
0.77
0.25
Non Current Investment
0.00
0.00
0.00
0.00
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
4.61
5.01
4.86
5.43
1.69
3.15
6.61
7.54
5.42
3.95
Other Non Current Assets
1.78
1.95
2.49
1.56
2.54
0.55
0.46
0.32
0.34
0.24
Current Assets
228.16
184.57
164.15
157.37
183.05
184.77
164.55
143.00
105.12
95.12
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
98.00
74.40
60.39
67.71
69.75
66.49
54.73
41.75
35.82
31.71
Sundry Debtors
93.98
75.31
67.20
49.60
64.70
64.05
61.80
56.94
44.98
45.49
Cash & Bank
7.61
5.39
3.85
3.13
4.32
4.15
4.71
4.63
5.49
3.02
Other Current Assets
28.56
12.49
4.69
4.07
44.28
50.07
43.31
39.66
18.83
14.89
Short Term Loans & Adv.
24.83
16.98
28.02
32.85
43.58
49.83
42.45
38.45
17.48
13.96
Net Current Assets
18.82
18.93
11.61
-2.12
19.81
30.36
21.31
31.81
12.77
8.35
Total Assets
311.01
260.53
240.08
238.39
261.31
260.18
233.33
211.03
163.86
154.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
-1.84
26.80
22.34
23.24
7.76
0.58
6.31
-19.35
14.53
13.31
PBT
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
Adjustment
21.44
17.15
21.14
19.01
17.41
15.14
14.79
11.46
11.69
10.43
Changes in Working Capital
-27.52
1.66
-2.80
17.94
-7.07
-16.18
-9.95
-32.66
-0.59
-2.59
Cash after chg. in Working capital
-1.34
28.00
22.45
23.42
10.13
1.84
7.72
-18.55
15.84
14.47
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.50
-1.20
-0.11
-0.17
-2.38
-1.27
-1.40
-0.80
-1.31
-1.16
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-22.18
-9.48
-5.53
-4.71
-8.04
-3.56
-7.96
-13.88
-5.30
-7.30
Net Fixed Assets
-13.94
-7.15
-3.66
-6.22
-4.61
-3.80
41.86
-12.93
-5.24
-15.62
Net Investments
0.00
0.00
-0.98
0.02
0.00
-7.42
1.16
-0.09
-1.07
0.04
Others
-8.24
-2.33
-0.89
1.49
-3.43
7.66
-50.98
-0.86
1.01
8.28
Cash from Financing Activity
24.40
-17.22
-16.63
-19.97
0.01
3.53
-5.94
32.37
-6.80
-7.52
Net Cash Inflow / Outflow
0.37
0.09
0.17
-1.44
-0.27
0.55
-7.58
-0.86
2.43
-1.51
Opening Cash & Equivalents
1.11
1.02
0.86
2.44
2.71
2.16
-17.72
5.49
3.02
4.53
Closing Cash & Equivalent
1.49
1.11
1.02
0.86
2.44
2.71
-25.30
4.63
5.45
3.02

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
40.66
38.92
35.52
36.99
47.02
45.86
44.06
41.09
41.32
43.48
ROA
0.92%
2.28%
1.97%
-5.16%
0.83%
0.15%
-0.18%
0.14%
2.23%
3.50%
ROE
4.31%
10.34%
8.97%
-21.65%
3.27%
0.59%
-0.69%
0.49%
7.00%
12.03%
ROCE
9.56%
12.33%
9.72%
-0.44%
6.88%
7.45%
7.59%
7.35%
10.88%
14.05%
Fixed Asset Turnover
2.55
2.60
2.47
1.83
2.58
2.80
2.72
2.01
2.06
2.18
Receivable days
101.56
92.48
85.08
121.92
104.42
108.60
92.23
91.87
86.58
82.73
Inventory Days
103.42
87.47
93.31
146.63
110.50
104.61
74.94
69.91
64.63
64.10
Payable days
165.90
132.11
111.21
90.28
86.70
99.47
88.16
89.31
79.05
72.93
Cash Conversion Cycle
39.08
47.85
67.18
178.27
128.22
113.74
79.02
72.47
72.17
73.90
Total Debt/Equity
2.05
1.80
2.09
2.26
1.85
1.69
1.49
1.68
0.93
1.08
Interest Cover
1.39
1.84
1.34
-0.06
0.98
1.31
1.34
1.41
1.73
1.93

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.